XML 84 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Loans and Notes Payable (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Total Notes Payable $ 3,592,341 $ 3,334,004
Loans and notes payable, current 3,236,529 2,477,970
Loans and notes payable, long term 355,812 856,034
Various Promissory Notes And Convertible Notes [Member]    
Debt Instrument [Line Items]    
Total Notes Payable 50,960 50,960
Novus Capital Group LLC Note [Member]    
Debt Instrument [Line Items]    
Total Notes Payable 171,554
National Buick GMC [Member]    
Debt Instrument [Line Items]    
Total Notes Payable 13,556 13,556
Blue Ridge Bank [Member]    
Debt Instrument [Line Items]    
Total Notes Payable 410,200 410,200
Small Business Administration [Member]    
Debt Instrument [Line Items]    
Total Notes Payable 349,579 299,900
Al Dali International for Gen. Trading & Cont. Co. [Member]    
Debt Instrument [Line Items]    
Total Notes Payable [1] 173,167 974,594
RSF, LLC [Member]    
Debt Instrument [Line Items]    
Total Notes Payable 500,000 500,000
Keke Mingo [Member]    
Debt Instrument [Line Items]    
Total Notes Payable 913,240
Justin Ellis [Member]    
Debt Instrument [Line Items]    
Total Notes Payable [2] 322,000
Cedarview Opportunities Master Fund L P [Member]    
Debt Instrument [Line Items]    
Total Notes Payable $ 1,772,879
[1] On September 9, 2024, Al Dali International for Gen. Trading & Cont. Co. (DIC) submitted a Notice of Exercise directly to our transfer agent to exercise its non-qualified stock option to purchase 1,000,000 shares of our common stock at an exercise price of $1.179 per share, which was originally issued as security to secure repayment of the note payable. We are currently analyzing the exercise of the stock option and related issuance of the shares to ensure they complied with the terms of our agreement with DIC. If we determine the issuance is in line with our agreement with DIC, then the remaining portion of note payable is anticipated to be paid out of operations of the RPC per the terms of the note agreement as previously disclosed.
[2] On July 8, 2024, we received a loan from a non-affiliated individual lender in the principal amount $350,000, and in connection therewith, the Company agreed to issue 15,982 ($35,000) restricted shares of the Company’s common stock. As of September 30, 2024, these shares have not been issued and are accrued for in accounts payable until issued. The loan bears interest at the rate of 10% per annum. The loan originally matured on December 31, 2024 and was amended on July 19, 2024 to mature on September 30, 2025. The note allows the holder to convert the outstanding principal and interest due under the note into shares of our common stock at price equal to 90% of the average closing price of our common stock for the previous five (5) trading days prior to the conversion date, with a floor conversion price of $1.00 per share. The lender may not convert amounts owed under the note if such conversion would cause him to own more than 4.99% of our common stock after giving effect to the issuance, which limitation may be raised to 9.99% upon from the lender.